From the ∗Department of Radiology, Beijing Tongren Hospital
†Clinical Center for Eye Tumors
‡Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University
§Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment
∥Huiying Medical Technology Co, Ltd, Beijing, China.
Received for publication November 19, 2021; accepted March 22, 2022.
Y.S. and X.X. contributed equally to this work and should therefore be regarded as equivalent authors.
Correspondence to: Wenbin Wei, MD, PhD, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, No. 1 Dongjiaominxiang Street, Dongcheng District, Beijing 100730, China (e-mail: [email protected]); Junfang Xian, MD, PhD, Department of Radiology, Beijing Tongren Hospital, Capital Medical University, No. 1 Dongjiaominxiang Street, Dongcheng District, Beijing 100730, China (e-mail: [email protected]).
This work was supported by the Beijing Municipal Administration of Hospitals' Ascent Plan (grant DFL20190203), Beijing Municipal Administration of Hospitals' Clinical Medicine Development of Special Funding Support (grant ZYLX201704), High Level Health Technical Personnel of Bureau of Health in Beijing (grant 2014-2-005), and Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment (grant 2016YNZL03).
The authors declare no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.
Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.jcat.org).